Increasing interest is noticed in the potential of volatile organic compound (VOC) analysis as
non-invasive diagnostic biomarker in clinical medical practice. The spectrum of VOCs …

Background Gut microbiota are known to be closely related to irritable bowel syndrome
(IBS). However, not much is known about characteristic fecal metabolic profiles of IBS. We …

To gain insight into the complex microbiome-gut-brain axis in irritable bowel syndrome (IBS),
several modalities of biological and clinical data must be combined. We aimed to identify …

The pathophysiology of irritable bowel syndrome and the detection of biomarkers of specific
mechanisms and/or predictors of therapeutic response remain elusive. This roadblock …

Irritable bowel syndrome (IBS), a common functional gastrointestinal disorder, is classified
according to bowel habits as IBS with constipation (IBS‐C), with diarrhea (IBS‐D), with …

Background Breath testing is becoming an important diagnostic method to evaluate many
disease states. In the light of rising healthcare costs, is important to develop a simple non …

Background and Aims Irritable bowel syndrome (IBS) is a pain disorder classified by bowel
habits, disregarding other factors that may influence the clinical course. The aim of this study …

As clinicians, we are trained to make a positive diagnosis of irritable bowel syndrome (IBS),
by using a combination of the most pertinent parts of the patient history, physical …

Background & Aims Irritable bowel syndrome (IBS) is a heterogeneous disorder, but
diagnoses and determination of subtypes are made based on symptoms. We profiled the …

Background: Most studies on gut microbiome of irritable bowel syndrome (IBS) have focused
on fecal microbiota, instead of mucosa-associated microbiota (MAM). Aims: The aim of this …